Table 3 Size, size distribution, zeta potential of ZnO NPs and BCD-ZnO NPs and encapsulation efficiency of drug (quercetin, naringin, ceftriaxone, ampicillin and amphotericin B) loaded BCD-ZnO NPs
S. no. | Nanoparticles (NPs) | Size range (nm) | Polydispersity Index (PDI) | Zeta potential (mV) | Drug encapsulation efficiency (EE%) |
|---|---|---|---|---|---|
1 | ZnO NPs | 15–25 | 0.101 | − 5.2 | – |
2 | BCD-ZnO NPs | 25–45 | 0.103 | − 9.7 | – |
1 | QT-ZnO-BCD NPs | 65–85 | 0.185 | − 11.6 | 52.5 |
2 | NAR-ZnO-BCD NPs | 75–95 | 0.131 | − 15.1 | 44.5 |
3 | CFT-ZnO-BCD NPs | 75–110 | 0.212 | − 14.7 | 47.5 |
4 | AMP-ZnO-BCD NPs | 70–90 | 0.127 | − 12.8 | 40.0 |
5 | AMB-ZnO-BCD NPs | 50–80 | 0.201 | − 13.4 | 49.5 |